Our research showed that Ang-2 was more highly expressed in the group of patients with lymph node metastasis and in the group of stage 3C-4 patients than in the group of patients with no lymph node metastasis and in the group of stage 0-3B patients. The gene discussed is ANGPT2; the disease is metastatic malignant neoplasm in the lymph nodes.